1. Haemodialysis Tunisian patient with acquired factor V inhibitor associated to arteriovenous shunt thrombosis
- Author
-
Wijdene El Borgi, Ikbel Ghachem, Fatma Ben Lakhal, Emna Gouider, Iheb Ghiriani, Amel Chelbi, and Sarra Fekih Salem
- Subjects
Male ,medicine.medical_specialty ,Tunisia ,Factor V Deficiency ,medicine.medical_treatment ,Factor V inhibitor ,Gastroenterology ,Arteriovenous Shunt, Surgical ,Postoperative Complications ,Renal Dialysis ,Internal medicine ,medicine ,Humans ,Renal Insufficiency, Chronic ,Aged ,Autoantibodies ,business.industry ,Antibiotic exposure ,Autoantibody ,Factor V ,Thrombosis ,General Medicine ,Blood Coagulation Disorders ,medicine.disease ,Arteriovenous shunt thrombosis ,Hemodialysis ,business - Abstract
Factor V deficiency is a rare hemostatic disorder. It may present with a diverse spectrum of symptoms due to a variety of mechanisms including development of autoantibodies associated with a number of conditions. We report a first case of factor V deficiency in Tunisian hemodialysis patient due to an autoantibody most likely secondary to antibiotic exposure responsible for an arteriovenous shunt thrombosis rather than bleeding. We discuss here the clinical and biological features of acquired factor V inhibitor and provide a short review of the current literature.
- Published
- 2020
- Full Text
- View/download PDF